2020 Akerna Cannabis Industry Mid-Year Review

Rhea-AI Summary

Akerna (KERN) released its mid-year review of the cannabis industry, highlighting significant trends and insights derived from recent market dynamics. The review emphasizes the industry's resilience and innovation, particularly during the COVID-19 pandemic. Key topics covered include the impact of cannabis legalization on economic recovery, consumer safety measures, and sales trends, revealing over $18 billion tracked in cannabis sales since 2010. Akerna aims to provide valuable business intelligence to investors, governments, and consumers for better decision-making in a rapidly evolving market.

Positive

• Akerna has tracked over $18 billion in cannabis sales since its inception in 2010.
• The mid-year review provides actionable insights for investors and stakeholders about the cannabis industry.

Negative

• No significant negative aspects reported.

DENVER, July 16, 2020 /PRNewswire/ -- Akerna (Nasdaq: KERN), a leading compliance technology provider and developer of the cannabis industry's first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), released its first state of the cannabis industry mid-year review.

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8728751-akerna-cannabis-2020-mid-year-review/  

100%; TEXT-ALIGN: left" dir="ltr">

"The last six months have shown us what it means to be strong, innovative, and resilient not only as an industry, but as a society. Our mid-year review delivers on our commitment to provide more value—more value to the cannabis, hemp, and CBD industries, to investors, to governments and to consumers and patients who deserve transparency and accountability in what they are putting in and on their bodies," said Jessica Billingsley, chief executive officer, Akerna. "We have curated what we believe is the most holistic and accurate picture of the cannabis industry today. This collection of actionable business intelligence serves as a reference for anyone interested in better understanding and decision making about the fastest growing industry in the world."

Read the Mid-Year Review: https://info.mjplatform.com/hubfs/072020%20MidYearReview_final.pdf

Cannabis Industry Mid-Year Review Highlights:

• Cannabis Capital Markets Analogy to The Tech Crash of Early 2000, Adoption, and Opportunity for Long Term Value, by Andy Sturner and Codie Sanchez, Entourage Effect Capital
• Cannabis Legalization as a tool for Economic Recovery, by Thomas Roth, Director of Regulatory Services, Akerna
• Counterfeiting and Product Safety An examination of how soloCode* can improve consumer confidence, by Gordon Wade, Founder of Category Management for the Consumer-Packaged Goods industry
• Cannabis as an Essential Business Observations of Innovation and Resilience During the COVID-19 Pandemic, by Nina Simosko, Chief Commercial Officer, Akerna
• The Cannabis Industry by the Numbers, What's Selling and Who Is Buying

About Akerna
Akerna is a global regulatory compliance technology company. Akerna's service offerings include MJ Platform®, Leaf Data Systems®, solo sciences tech platform and Ample Organics. Since its establishment in 2010, Akerna has tracked more than $18 billion in cannabis sales. Akerna is based in Denver. For more information, please visit www.akerna.com and follow us on Twitter @AkernaCorp.

100%; TEXT-ALIGN: left" dir="ltr">

 

100%; TEXT-ALIGN: left" dir="ltr">

 

100%; TEXT-ALIGN: left" dir="ltr">

 

View original content:http://www.prnewswire.com/news-releases/2020-akerna-cannabis-industry-mid-year-review-301094568.html

SOURCE Akerna Corp.

FAQ

What is the significance of Akerna's mid-year review for the KERN stock?

The mid-year review provides insights that may positively influence investor sentiment and decision-making regarding KERN stock.

What key trends were highlighted in Akerna's cannabis industry review?

The review highlights trends in legalization, safety measures, and changing consumer behaviors in the cannabis market.

How has Akerna tracked cannabis sales since 2010?

Akerna has tracked over $18 billion in cannabis sales as part of its commitment to compliance and market analysis.

What impact does cannabis legalization have on economic recovery according to Akerna?

Akerna's review discusses cannabis legalization as a vital tool for economic recovery amid challenging times.